Showing results (51-60 of 372) with videos related to

Sort By:
Pageof 38
The Lancet. Rheumatology|July 20, 2024
Arthritis complicating inflammatory bowel disease- the future is nowKaiyang Song, Jack Satsangi, Laura C Coates
The Journal of Rheumatology. Supplement|June 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology|March 2, 2021
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next StepsWilliam Tillett, Neil McHugh, Ana-Maria Orbai, et al.
ACR Open Rheumatology|May 19, 2026
Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 StudiesLaure Gossec, William Tillett, Laura C Coates, et al.
Current Rheumatology Reports|March 14, 2014
Patient involvement in outcome measures for psoriatic arthritisWilliam Tillett, Ade Adebajo, Mel Brooke, et al.
Rheumatology (Oxford, England)|July 1, 2026
Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOSTLaura C Coates, Dafna D Gladman, Joseph F Merola, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.
The Journal of Rheumatology|March 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.
RMD Open|January 17, 2023
Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort studyWilliam Tillett, Alexis Ogdie, Alun Passey, et al.
Pageof 38